AnemiaAnemia, AplasticBlast InjuriesAnemia, HemolyticAnemia, Refractory, with Excess of BlastsAnemia, RefractoryFanconi AnemiaAnemia, Hemolytic, AutoimmuneAnemia, HypochromicAnemia, MacrocyticAnemia, PerniciousAnemia, SideroblasticAnemia, Sickle CellRefractory Period, ElectrophysiologicalAnemia, MegaloblasticHemoglobinsInfectious Anemia Virus, EquineTreatment OutcomeAnemia, Hemolytic, CongenitalErythropoietinLeukemia, Myeloid, AcuteEquine Infectious AnemiaChicken anemia virusAnemia, Dyserythropoietic, CongenitalIronAnemia, Diamond-BlackfanLeukemia, MyeloidBone MarrowSalvage TherapyFanconi Anemia Complementation Group ProteinsRecurrencePregnancy Complications, HematologicAnemia, NeonatalDrug Administration ScheduleCytarabineHematinicsAntineoplastic AgentsTime FactorsAntineoplastic Combined Chemotherapy ProtocolsHematocritErythropoiesisRemission InductionFanconi Anemia Complementation Group C ProteinMyelodysplastic SyndromesFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group A ProteinRetrospective StudiesDrug Resistance, NeoplasmAcute DiseaseFerritinsFollow-Up StudiesOryza sativaErythrocyte CountAntibodies, MonoclonalBlood TransfusionAnemia, Hemolytic, Congenital NonspherocyticPallorErythrocytesDose-Response Relationship, DrugPrecursor Cell Lymphoblastic Leukemia-LymphomaMolecular Sequence DataErythrocyte IndicesExplosionsHemoglobinometryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug ResistanceThrombocytopeniaInfusions, IntravenousLeukemia, LymphoidPrognosisBlood Cell CountAntibodies, Monoclonal, Murine-DerivedRisk FactorsNeoplasmsRecombinant ProteinsProspective StudiesTreatment FailureSurvival AnalysisImmunosuppressive AgentsMutationThalidomideChronic DiseaseFanconi Anemia Complementation Group G ProteinCoombs TestReticulocyte CountSurvival RateIron, DietaryBone Marrow CellsEtoposideBase SequenceDrug Therapy, CombinationDisease-Free SurvivalPancytopeniaHematopoietic Stem CellsPrevalenceIron CompoundsDrug EvaluationCyclophosphamideAnticonvulsantsHepcidins